Triazine antiviral compounds
US6335339B1 · kind B1 · utility
14Cited by
9References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 1999 |
| Grant date | Jan 1, 2002 |
| Priority date | — |
| Expiry date | Jan 13, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pharmaceutical formulations comprising 1,3,5-triazine derivatives. The compounds and formulations of the present invention exhibit a range of activities, including antiviral and antibiotic activities, and the formulations may be used, alone or in combination, as a method of treating a patient in need of antiviral and/or antibiotic therapy. The triazine derivatives of the present invention bind to and inhibit functional nucleic acids, and hence, have broad applicability in the treatment of conditions associated with DNA and RNA viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.